Biodegradable and biocompatible medical products, namely adhesives, sealants, and hemostats

A medical product, comprising:

• a liquid composition including
• a plurality of substituted 1,2-dithiolane monomers, the substituted 1,2-dithiolane monomers functional to polymerize through a ring-opening reaction to form a polydisulfide polymer having
• a first active thiol end and a second active thiol end;
• and,
• a plurality of repeating units having a substituted dithioalkyl structure from the ring opening reaction as follows
• 1 wherein,
• n is 3;
• each Ri and Rk is independently selected from the group consisting of H;
• alkyl, cycloalkyl, alkenyl, alkynyl, and aryl groups, each of the groups having from 1-8 carbons;
• hydroxylated alkyl, cycloalkyl, alkenyl, alkynyl, and aryl groups, each of the groups having from 1-8 carbons;
• and, carboxylated alkyl, cycloalkyl, alkenyl, alkynyl, and aryl groups, each of the groups having from 1-8 carbons;
• wherein, i and k are integers, and at least one Ri or Rk in each repeating unit includes a carbonyl functionality;
• and,
• m is an integer selected to match a desired molecular weight of the polymer;
• and,
• a plurality of stabilizer molecules configured to stabilize the first active thiol end of the polymer, the plurality of stabilizer molecules being the substituted cyclic disulfide molecules derivatized to include a functional group that forms a first labile bond with the first active thiol end, the first labile bond selected from the group consisting of a thioester bond, a thiocarbamate bond, and a thioether bond;
• the polydisulfide polymer formed by reacting the plurality of monomers and the plurality of stabilizers in the liquid;
• or,
• a combination of the liquid and the polydisulfide polymer;
• wherein,
• the repeating units and the stabilizer molecules are the same, or substantially the same, chemical moieties following a depolymerization of the polymer;
• and,
• the polymer is biocompatible and biodegradable for a medical use.